Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
bioMerieux
bioMerieux
Activities:
Regulatory
Analysis
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
bioMérieux and JMI Laboratories partner to fight antimicrobial resistance
JMI Laboratories is a recent member of the Element Group, a leading global Testing, Inspection and Certification (TIC) company, through acquisition in November 2021
Drug Delivery
InDevR raises $9m in series B financing
ioMérieux will also become the exclusive distributor of the VaxArray portfolio in Europe
Regulatory
bioMérieux receives FDA clearance for mass spectrometry ID system
With 1.3 million deaths worldwide annually, antimicrobial resistance (AMR) is a global health priority
Manufacturing
Recombinant Factor C assay to aid demand for LAL endotoxin testing
Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Analysis
bioMérieux launches automated diagnostic solution for microbial detection
EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance
BioMérieux acquires Hyglos for a total consideration of €24m
Expands its offering for the detection of endotoxins in pharmaceutical products
Analysis
Revolutionised and Robust: Environmental Identification Webinar - mid-October
Environmental identification, including moulds, by MALDI-TOF Mass Spectrometry
Subscribe now